1.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ACTG A5264, 1U01AI068636, NCT01352117
|
|
2.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI, Other Protocol IDs: ACTG A5263, 1U01AI068636, U01CA121947, NCT01435018
|
|
3.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-02923, AMC-070, U01CA121947, CDR0000664131, NCT01057121
|
|
4.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2011-01412, 10-049, CDR0000680558, MSKCC-10049, U01CA069856, 8406, NCT01154452
|
|
5.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 120047, 12-C-0047, NCT01495598
|
|
6.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: STH16059, 2011-003099-35, NCT01752569
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 090130, 09-C-0130, NCT00923936
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CKS/IND-CX/05, NCT01067690
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 16 and over Sponsor: Other Protocol IDs: STH15195, 2008-006007-23, NCT01140737
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 19 to 75 Sponsor: Other Protocol IDs: 2010-022898-33, ANRS 154 LENAKAP, NCT01282047
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: C41-10, NCT01296815
|
|
12.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-03170, AMC-063, U01CA121947, CDR0000659554, NCT01016730
|
|
13.
|
Phase: No phase specified Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 110220, 11-C-0220, NCT01419561
|